510(k) Report

510(k) · Cleared

Cleared

Cliniscansm Eeg

K141883510(k) TraditionalCleared May 15, 2015308-day reviewClass II21 CFR 882.1400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Picofemto, LLC · OMB Automatic Event Detection Software For Full-Montage Electroencephalograph

Cleared on May 15, 2015 as substantially equivalent to K011397 (Persyst Development Corp., 2001) and 1 other predicate after a 308-day review. Its family tree reaches back 1 generation to 2001.

Decided
May 15, 2015
Review
308 days
Class
Class II
Product code
OMB
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K001781 (2001). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2001: 1 other ancestorK001781 · Curry Multimodal Neuroimaging Software · Neurosoft, Inc. · 20012000200520102015
Other ancestors, by generation 1 generation back: 1 other ancestor K001781 · Curry Multimodal Neuroimaging Software · Neurosoft, Inc. · 20010
  1. Root · 1 generation backK001781 Curry Multimodal Neuroimaging SoftwareNeurosoft, Inc. · 2001
  2. This deviceK141883 Cliniscansm EegPicofemto, LLC · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K001781Curry Multimodal Neuroimaging SoftwareNeurosoft, Inc.2001—
0 (this device)K141883Cliniscansm EegPicofemto, LLC2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
FIG. 1 — Lineage of K141883, 2001–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OMB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OMB device

  1. #1 K240993 encevis (2.1)score 15.0 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011397Persyst Reveal
Summary page 4
…n 21 CFR 882.1400 Number: Predicate The CliniscanSM EEG is substantially equivalent to the Persyst ® Reveal [FDA 510(k) Devices: number K011397] and Neurosoft Curry 7 [FDA 510(k) number K001781]. Device CliniscanSM EEG, a Picofemto product, is a clin…
Persyst Development Corp.2001—
*K001781Curry Multimodal Neuroimaging Software
Summary page 4
…The CliniscanSM EEG is substantially equivalent to the Persyst ® Reveal [FDA 510(k) Devices: number K011397] and Neurosoft Curry 7 [FDA 510(k) number K001781]. Device CliniscanSM EEG, a Picofemto product, is a clinical decision support system for medical Descripti…
Neurosoft, Inc.2001—

Also cleared against K011397: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 3 other devices also cite its predicate K011397.

How does its category compare?

All OMB devices

OMB Automatic Event Detection Software For Full-Montage Electroencephalograph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · OMB

5in 2025

2009: 12010: 12012: 12013: 12014: 22015: 32017: 12018: 32019: 12020: 12021: 12022: 12023: 22024: 52025: 52026 (partial year): 1
2007high 5 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OMB

143in 2025

2015: 233 days median2018: 108 days median2024: 201 days median2025: 143 days median
2007high 233 (2015) · low 108 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OMB

1in 2021

2021: 1
2007high 1 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OMB

6in 2025

2011: 12014: 22022: 12023: 42024: 212025: 6
2007high 21 (2024) · low 0 (2007)2025

MAUDE reports naming product code OMB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20101—00
20110—01
20121—00
20131—00
20142—02
2015323300
20160—00
20171—00
2018310800
20191—00
20201—00
20211—10
20221—01
20232—04
20245201021
2025514306
20261—0—

What is it indicated for?

1. CliniscanSM EEG is a clinical decision support system for medical data, to assist healthcare professionals in the visualization and analysis of EEG data. 2. The Seizure Detection component of CliniscanSM EEG is intended to mark previously acquired sections of adult (greater than or equal to 18 years) EEG recordings that may correspond to electrographic seizures, in order to assist qualified clinical practitioners in the assessment of EEG traces. 3.…

Read the full statement (186 words)

1. CliniscanSM EEG is a clinical decision support system for medical data, to assist healthcare professionals in the visualization and analysis of EEG data.

2. The Seizure Detection component of CliniscanSM EEG is intended to mark previously acquired sections of adult (greater than or equal to 18 years) EEG recordings that may correspond to electrographic seizures, in order to assist qualified clinical practitioners in the assessment of EEG traces.

3. CliniscanSM EEG is intended for use on EEG recordings acquired using full scalp montage according to the standard 10/20 system.

4. The user may annotate the data, and the annotations are stored with the EEG recording in the cloud.

5. CliniscanSM EEG displays standard qEEG features to the user including FFT Power Spectrum, Coherence Mapping (EEG Activity Mapping), Density Spectral Array, EEG Localization Maps, and Wavelet Subband Decomposition (Delta, Theta, Alpha, Beta, and Gamma).

6. CliniscanSM EEG detects seizure events for review by qualified medical professionals.

7. CliniscanSM EEG is designed to provide analytics data derived from a patient’s input EEG data. It is NOT designed to provide definitive diagnoses of diseases or treatments of ailments.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K141883: Cliniscansm Eeg.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K141883

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026